搜尋結果
2024年6月7日 · FDA approves GSK’s RSV vaccine for high-risk adults ages 50 to 59, expanding shot’s reach. The Food and Drug Administration expanded the approval of GSK’s respiratory syncytial virus vaccine ...
6 天前 · The FDA has approved Moderna’s RSV vaccine for older adults. Courtesy: Moderna. Moderna Inc respiratory syncytial virus (RSV) shot mRESVIA showed 50% efficacy in preventing RSV after 18 months ...
2023年1月18日 · Moderna and Pfizer produced Covid-19 vaccines in record times, shaving years off the traditional vaccine research and approval process, and now the same expedited timeline is occurring for RSV in...
2024年5月31日 · Key Points. The Food and Drug Administration approved Moderna's vaccine for respiratory syncytial virus. The decision is a win for Moderna, which desperately needs another revenue source amid ...
2023年9月6日 · New Covid vaccines from Moderna and Pfizer generated a strong immune response against BA.2.86, a highly mutated omicron variant that health officials are watching closely. Moderna, Pfizer and ...
2021年7月3日 · Moderna delivered the first doses of its Covid-19 vaccine to the NIH for testing on Feb. 24, 2020, and “the first Moderna shot went into a volunteer’s arm in Seattle on March 16, 2020 ...
2021年8月27日 · CNBC Exclusive: How Moderna and Pfizer-BioNTech developed vaccines in record time. Key Points. Developing a vaccine in less than a year for a novel pathogen had never been done before Covid-19 ...
